SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-015739
Filing Date
2018-08-16
Accepted
2018-08-16 07:30:25
Documents
39
Period of Report
2018-08-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K navb20180815c_8k.htm 8-K 21315
2 EXHIBIT 99.1 ex_121985.htm EX-99.1 22526
3 EXHIBIT 99.2 ex_121986.htm EX-99.2 20352
4 a35.jpg GRAPHIC 144612
5 a34.jpg GRAPHIC 179755
6 a33.jpg GRAPHIC 303141
7 a32.jpg GRAPHIC 200925
8 a31.jpg GRAPHIC 133210
9 a30.jpg GRAPHIC 192768
10 a29.jpg GRAPHIC 210979
11 a28.jpg GRAPHIC 202514
12 a27.jpg GRAPHIC 228953
13 a26.jpg GRAPHIC 155410
14 a25.jpg GRAPHIC 213172
15 a24.jpg GRAPHIC 180016
16 a23.jpg GRAPHIC 114976
17 a22.jpg GRAPHIC 250034
18 a21.jpg GRAPHIC 72314
19 a20.jpg GRAPHIC 180963
20 a19.jpg GRAPHIC 194435
21 a18.jpg GRAPHIC 149632
22 a17.jpg GRAPHIC 260183
23 a16.jpg GRAPHIC 222547
24 a15.jpg GRAPHIC 297529
25 a14.jpg GRAPHIC 247522
26 a13.jpg GRAPHIC 67339
27 a12.jpg GRAPHIC 184943
28 a11.jpg GRAPHIC 145639
29 a10.jpg GRAPHIC 176706
30 a09.jpg GRAPHIC 183029
31 a08.jpg GRAPHIC 60516
32 a07.jpg GRAPHIC 265243
33 a06.jpg GRAPHIC 149979
34 a05.jpg GRAPHIC 176706
35 a04.jpg GRAPHIC 213608
36 a03.jpg GRAPHIC 221231
37 a02.jpg GRAPHIC 173750
38 a01.jpg GRAPHIC 166796
39 logo01.jpg GRAPHIC 3211
  Complete submission text file 0001437749-18-015739.txt   9031015
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Filer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35076 | Film No.: 181022309
SIC: 2835 In Vitro & In Vivo Diagnostic Substances